Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy—a single center experience

Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy—a single center experience

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by enhancing T-cell-mediated immune responses against tumors. However, their use can lead to immune-related adverse events (irAEs) impacting patient outcomes. This single-center, observational study investigates the relationship...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Rudzińska, Pola Juchaniuk, Jakub Oberda, Kamila Krukowska, Sylwia Krzyśkowska, Eliza Kuchta, Anna Rodzajewska, Mariola Janiszewska, Katarzyna Machulska-Ciuraj, Katarzyna Szklener
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
cancer immunotherapy
immunotherapy toxicity
immune checkpoint inhibitors
immunotherapy adverse effects
immune check inhibitor (ICI)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1527103/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1527103/full

Similar Items